Literature DB >> 36033940

Developing a Comprehensive, Adaptive, and International Biosafety and Biosecurity Program for Advanced Biotechnology: The iGEM Experience.

Piers Millett1, Thomas Binz2, Sam Weiss Evans3, Todd Kuiken4, Ken Oye5, Megan J Palmer6, Cécile van der Vlugt7, Kathrina Yambao8, Samuel Yu9.   

Abstract

Introduction: The international synthetic biology competition iGEM (formally known as the international Genetically Engineered Machines competition) has a dedicated biosafety and biosecurity program. Method: A review of specific elements of the program and a series of concrete examples illustrate how experiences in implementing the program have helped improved policy, including an increasing diversity of sources for genetic parts and organisms, keeping pace with technical developments, considering pathways toward future environmental release, addressing antimicrobial resistance, and testing the efficacy of current biosecurity arrangements.
Results: iGEM's program is forward-leaning, in that it addresses both traditional (pathogen-based) and emerging risks both in terms of new technologies and new risks. It is integrated into the technical work of the competition-with clearly described roles and responsibilities for all members of the community. It operates throughout the life cycle of projects-from project design to future application. It makes use of specific tools to gather and review biosafety and biosecurity information, making it easier for those planning and conducting science and engineering to recognize potential risks and match them with appropriate risk management approaches, as well as for specialists to review this information to identify gaps and strengthen plans. Discussion: Integrating an increasingly adaptive risk management approach has allowed iGEM's biosafety and biosecurity program to become comprehensive, be cross-cutting, and cover the competition's life cycle. © ABSA International 2019.

Entities:  

Keywords:  adaptive biosafety; biological engineering; biotechnology; genetic engineering; iGEM; synthetic biology

Year:  2019        PMID: 36033940      PMCID: PMC9387731          DOI: 10.1177/1535676019838075

Source DB:  PubMed          Journal:  Appl Biosaf        ISSN: 1535-6760


  2 in total

1.  Designing safety policies to meet evolving needs: iGEM as a testbed for proactive and adaptive risk management.

Authors:  Julie McNamara; Shlomiya Bar-Yam Lightfoot; Kelly Drinkwater; Evan Appleton; Kenneth Oye
Journal:  ACS Synth Biol       Date:  2014-12-19       Impact factor: 5.110

2.  Synthetic Biology Ethics at iGEM: iGEMer Perspectives.

Authors:  Christopher M Whitford; Nils-Christian Lübke; Christian Rückert
Journal:  Trends Biotechnol       Date:  2018-07-07       Impact factor: 19.536

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.